Dan Leonard
Stock Analyst at UBS
(3.83)
# 663
Out of 4,944 analysts
299
Total ratings
53.01%
Success rate
7.34%
Average return
Main Sectors:
Stocks Rated by Dan Leonard
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TXG 10x Genomics | Maintains: Neutral | $12 → $13 | $12.81 | +1.48% | 6 | Aug 8, 2025 | |
| EXAS Exact Sciences | Maintains: Neutral | $61 → $53 | $41.74 | +26.98% | 10 | Aug 7, 2025 | |
| CERT Certara | Maintains: Buy | $18 → $15 | $10.75 | +39.53% | 10 | Aug 7, 2025 | |
| MEDP Medpace Holdings | Downgrades: Sell | $300 → $305 | $459.29 | -33.59% | 2 | Jul 29, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Neutral | $460 → $500 | $477.41 | +4.73% | 17 | Jul 24, 2025 | |
| DHR Danaher | Maintains: Buy | $240 → $225 | $205.72 | +9.37% | 18 | Jul 23, 2025 | |
| IQV IQVIA Holdings | Maintains: Buy | $185 → $225 | $185.91 | +21.03% | 16 | Jul 23, 2025 | |
| MTD Mettler-Toledo International | Upgrades: Buy | $1,530 → $1,350 | $1,292.89 | +4.42% | 9 | May 20, 2025 | |
| TECH Bio-Techne | Maintains: Buy | $95 → $70 | $52.83 | +32.50% | 11 | May 9, 2025 | |
| BRKR Bruker | Maintains: Neutral | $57 → $45 | $32.36 | +39.06% | 11 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $355 → $310 | $274.76 | +12.83% | 20 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $355 → $310 | $271.71 | +14.09% | 20 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $70 | $55.10 | +27.04% | 9 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $145 → $115 | $88.00 | +30.68% | 2 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $122 → $99 | $94.87 | +4.35% | 1 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $29 → $25 | $12.66 | +97.47% | 7 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $250 → $185 | $152.75 | +21.11% | 6 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $9 | $8.49 | +6.01% | 2 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $35 | $21.01 | +66.59% | 4 | Dec 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $160 → $150 | $117.32 | +27.86% | 21 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $225 → $200 | $97.38 | +105.38% | 16 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $11 | $2.69 | +308.92% | 6 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $70 | $159.81 | -56.20% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Underperform | $7 | $12.66 | -44.71% | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $345 | $285.52 | +20.83% | 12 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $260 | $169.08 | +53.77% | 5 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $160 → $145 | $178.68 | -18.85% | 10 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $95 → $90 | $67.95 | +32.45% | 12 | Feb 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $62 → $64 | $48.97 | +29.98% | 3 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $330 → $340 | $269.31 | +26.25% | 11 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $24 | $21.83 | +9.94% | 1 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $45 → $35 | $6.03 | +480.43% | 12 | Aug 14, 2019 |
10x Genomics
Aug 8, 2025
Maintains: Neutral
Price Target: $12 → $13
Current: $12.81
Upside: +1.48%
Exact Sciences
Aug 7, 2025
Maintains: Neutral
Price Target: $61 → $53
Current: $41.74
Upside: +26.98%
Certara
Aug 7, 2025
Maintains: Buy
Price Target: $18 → $15
Current: $10.75
Upside: +39.53%
Medpace Holdings
Jul 29, 2025
Downgrades: Sell
Price Target: $300 → $305
Current: $459.29
Upside: -33.59%
Thermo Fisher Scientific
Jul 24, 2025
Maintains: Neutral
Price Target: $460 → $500
Current: $477.41
Upside: +4.73%
Danaher
Jul 23, 2025
Maintains: Buy
Price Target: $240 → $225
Current: $205.72
Upside: +9.37%
IQVIA Holdings
Jul 23, 2025
Maintains: Buy
Price Target: $185 → $225
Current: $185.91
Upside: +21.03%
Mettler-Toledo International
May 20, 2025
Upgrades: Buy
Price Target: $1,530 → $1,350
Current: $1,292.89
Upside: +4.42%
Bio-Techne
May 9, 2025
Maintains: Buy
Price Target: $95 → $70
Current: $52.83
Upside: +32.50%
Bruker
May 8, 2025
Maintains: Neutral
Price Target: $57 → $45
Current: $32.36
Upside: +39.06%
May 2, 2025
Maintains: Buy
Price Target: $355 → $310
Current: $274.76
Upside: +12.83%
May 2, 2025
Maintains: Buy
Price Target: $355 → $310
Current: $271.71
Upside: +14.09%
May 1, 2025
Maintains: Buy
Price Target: $65 → $70
Current: $55.10
Upside: +27.04%
May 1, 2025
Upgrades: Buy
Price Target: $145 → $115
Current: $88.00
Upside: +30.68%
Apr 7, 2025
Maintains: Overweight
Price Target: $122 → $99
Current: $94.87
Upside: +4.35%
Jan 17, 2025
Downgrades: Neutral
Price Target: $29 → $25
Current: $12.66
Upside: +97.47%
Jan 17, 2025
Downgrades: Neutral
Price Target: $250 → $185
Current: $152.75
Upside: +21.11%
Oct 18, 2024
Maintains: Neutral
Price Target: $7 → $9
Current: $8.49
Upside: +6.01%
Dec 7, 2023
Initiates: Neutral
Price Target: $35
Current: $21.01
Upside: +66.59%
Aug 16, 2023
Maintains: Outperform
Price Target: $160 → $150
Current: $117.32
Upside: +27.86%
Aug 10, 2023
Maintains: Neutral
Price Target: $225 → $200
Current: $97.38
Upside: +105.38%
Aug 8, 2023
Maintains: Neutral
Price Target: $14 → $11
Current: $2.69
Upside: +308.92%
Aug 4, 2023
Reiterates: Outperform
Price Target: $70
Current: $159.81
Upside: -56.20%
Feb 15, 2023
Reiterates: Underperform
Price Target: $7
Current: $12.66
Upside: -44.71%
Aug 25, 2022
Initiates: Neutral
Price Target: $345
Current: $285.52
Upside: +20.83%
Aug 25, 2022
Initiates: Neutral
Price Target: $260
Current: $169.08
Upside: +53.77%
Feb 4, 2022
Maintains: Equal-Weight
Price Target: $160 → $145
Current: $178.68
Upside: -18.85%
Feb 3, 2022
Maintains: Overweight
Price Target: $95 → $90
Current: $67.95
Upside: +32.45%
Dec 14, 2021
Maintains: Equal-Weight
Price Target: $62 → $64
Current: $48.97
Upside: +29.98%
Dec 14, 2021
Maintains: Overweight
Price Target: $330 → $340
Current: $269.31
Upside: +26.25%
Aug 10, 2021
Initiates: Overweight
Price Target: $24
Current: $21.83
Upside: +9.94%
Aug 14, 2019
Maintains: Hold
Price Target: $45 → $35
Current: $6.03
Upside: +480.43%